CONTEXTVISION AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.86 NOK | -2.01% |
|
-4.56% | -23.90% |
| Apr. 03 | ContextVision Announces New Image Quality Advancements in X-Ray | CI |
| Feb. 16 | Transcript : ContextVision AB, Q4 2023 Earnings Call, Feb 16, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
ContextVision AB is a Sweden-based medical technology software company specialized in image analysis and artificial intelligence. The Company is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The Company develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVisionâs cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The Company operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.
Calendar
2024-05-08
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
5.98
NOK
Average target price
6.5
NOK
Spread / Average Target
+8.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -23.90% | 42.08M | |
| +3.14% | 32.58B | |
| +16.26% | 7.65B | |
| +21.60% | 3.92B | |
| -16.02% | 3.19B | |
| -28.75% | 1.26B | |
| -31.01% | 1.14B | |
| -34.81% | 926M | |
| +1.34% | 908M | |
| -23.83% | 859M |
- Stock Market
- Equities
- CONTX Stock
- News ContextVision AB
- ContextVision Names CFO
